Ranbaxy Laboratories swung to a loss for the quarter ended March 2014. During the quarter, the company reported a loss of Rs 736.54 million compared with a profit of Rs 1,257.59 million in the same quarter previous year.
Net sales for the quarter declined marginally 0.20% to Rs 24,668.21 million, compared with Rs 24,718.34 million for the prior year period.
Earnings per share stood negative at Rs 1.73 compared with Rs 2.97 in same quarter last year.
| Quarterly Results - (Rs in mn) |
| As at | Mar - 14 | Mar - 13 | %Change |
| Net Sales | 24,668.21 | 24,718.34 | (0.20) |
| Net Profit | (736.54) | 1,257.59 | - |
| Basic EPS | (1.73) | 2.97 | - |
Shares of the company declined Rs 5.9, or 1.26%, to trade at Rs 463.60. The total volume of shares traded was 423,554 at the BSE (3.45 p.m., Friday).
